Immuron ceo, steven lydeamore to present at h.c. wainwright

Melbourne, australia, sept. 11, 2023 (globe newswire) -- immuron limited (asx: imc; nasdaq: imrn), an australian based and globally integrated biopharmaceutical company is pleased to advise our chief executive officer, steven lydeamore will be presenting virtually at the h.c. wainwright 25th annual global investment conference on september 11th.

IMRN Ratings Summary

IMRN Quant Ranking